Randomised study of 2 low doses of sunitinib to modulate tumor microvasculature prior to chemotherapy in nasopharyngeal carcinoma (NPC).
Tan C, Wang T, Lim C, Loh T, Chin S, Sundar R, Chong W, Ow S, Soo R, Lee S, Goh B. Randomised study of 2 low doses of sunitinib to modulate tumor microvasculature prior to chemotherapy in nasopharyngeal carcinoma (NPC). Journal Of Clinical Oncology 2016, 34: 6034-6034. DOI: 10.1200/jco.2016.34.15_suppl.6034.Peer-Reviewed Original Research